Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...
Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Dancing With The Stars' pro Rylee Arnold, 19, was diagnosed with Type 1 diabetes when she was 15. Here's her story—in her own ...
Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.
I received my new 2025 Part D premium with the plan increase going up by 250% from $25 a month to over $60. I was informed ...
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon”) (Nasdaq: ELDN) today reported its third quarter 2024 operating and financial results and reviewed recent ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback